Home > Press > Nanosys Signs Two Cooperation Agreements With Harvard University to Combine Intellectual Property Assets Covering Fundamental Nanowire Technology to Address Non-Volatile Memory and
Abstract:
The Combined IP Portfolio Offers Attractive Opportunity for Companies Seeking to License Leading Nanowire Technologies
Nanosys Inc. today announced that it has signed two agreements with Harvard University to combine their extensive intellectual property (IP) assets to facilitate out-licensing in two areas: nanowire-based biosensors and nanowire-based non-volatile memories. The IP is available for out-licensing to any interested third parties. The technologies being made available originate from the laboratory of Dr. Charles Lieber (Mark Hymen Professor of Chemistry at Harvard University), as well as many other nanotech researchers at Nanosys and other universities associated with Nanosys. The IP on offer includes Nanosys' extensive portfolio covering all aspects of nanowire production, functionalization, material interface technologies, fabrication technologies, basic devices using nanostructures, applications and architectures, and Harvard's portfolio of nanowire-based biosensor and non-volatile memory related IP.
"The agreements between Nanosys and Harvard reflect an innovative strategy to facilitate the development of two novel disruptive technologies," said Isaac T. Kohlberg, Harvard University's Senior Associate Provost and Chief Technology Development Officer. "We're delighted to be working in concert with Nanosys, a recognized leader in the nanowire space, to identify companies interested in acquiring rights to our innovative nanowire technologies for next-generation biosensors and non-volatile memory."
Andrew Filler, General Counsel and Vice-President of Intellectual Property at Nanosys, commented: "As companies are now realizing the significant commercial value of nanotechnology to expand upon and open up new markets, our goal is to help these companies address these markets using our intellectual property portfolio." He added, "After developing many fundamental technology platforms at Nanosys over the last several years, the company is now focused on commercializing technologies in core business areas including solid state lighting, electronics, energy storage and medical device applications. Our nanotechnology licensing program complements our core business focus, thereby providing the market with a convenient licensing option to our fundamental patent portfolio in areas that we are not fully exploiting ourselves."
####
About Nanosys Inc.
Nanosys, Inc. is a leader in the development of nanotechnology-enabled products utilizing high performance inorganic nanostructures. Nanosys has built one of the broadest technology platforms in the industry with over 650 patents and patent applications covering fundamental areas of nanotechnology. Based in Palo Alto, California and privately held, Nanosys collaborates with industry leaders to develop revolutionary high-value, high-performance products for life sciences, computing, optoelectronics, renewable energy, and defense.
For more information, please click here
Contacts:
Nanosys Contact:
Andrew Filler
General Counsel and Vice President of Intellectual Property
Tel. 650 331-2176
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Chip Technology
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Nanoelectronics
Interdisciplinary: Rice team tackles the future of semiconductors Multiferroics could be the key to ultralow-energy computing October 6th, 2023
Key element for a scalable quantum computer: Physicists from Forschungszentrum Jülich and RWTH Aachen University demonstrate electron transport on a quantum chip September 23rd, 2022
Reduced power consumption in semiconductor devices September 23rd, 2022
Atomic level deposition to extend Moore’s law and beyond July 15th, 2022
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||